Logo image of ELMD

ELECTROMED INC (ELMD) Stock Fundamental Analysis

NYSEARCA:ELMD - NYSE Arca - US2854091087 - Common Stock - Currency: USD

20.15  -0.33 (-1.61%)

Fundamental Rating

7

Overall ELMD gets a fundamental rating of 7 out of 10. We evaluated ELMD against 188 industry peers in the Health Care Equipment & Supplies industry. ELMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ELMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make ELMD a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

ELMD had positive earnings in the past year.
In the past year ELMD had a positive cash flow from operations.
ELMD had positive earnings in each of the past 5 years.
ELMD had a positive operating cash flow in 4 of the past 5 years.
ELMD Yearly Net Income VS EBIT VS OCF VS FCFELMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

1.2 Ratios

ELMD has a better Return On Assets (13.65%) than 95.74% of its industry peers.
The Return On Equity of ELMD (16.30%) is better than 91.49% of its industry peers.
ELMD has a better Return On Invested Capital (15.35%) than 96.28% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELMD is in line with the industry average of 7.89%.
The 3 year average ROIC (8.56%) for ELMD is below the current ROIC(15.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.65%
ROE 16.3%
ROIC 15.35%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ELMD Yearly ROA, ROE, ROICELMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELMD's Profit Margin of 11.66% is amongst the best of the industry. ELMD outperforms 88.83% of its industry peers.
ELMD's Profit Margin has improved in the last couple of years.
The Operating Margin of ELMD (14.58%) is better than 84.57% of its industry peers.
ELMD's Operating Margin has improved in the last couple of years.
ELMD has a Gross Margin of 77.55%. This is amongst the best in the industry. ELMD outperforms 91.49% of its industry peers.
In the last couple of years the Gross Margin of ELMD has remained more or less at the same level.
Industry RankSector Rank
OM 14.58%
PM (TTM) 11.66%
GM 77.55%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
ELMD Yearly Profit, Operating, Gross MarginsELMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ELMD is still creating some value.
Compared to 1 year ago, ELMD has more shares outstanding
Compared to 5 years ago, ELMD has more shares outstanding
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ELMD Yearly Shares OutstandingELMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ELMD Yearly Total Debt VS Total AssetsELMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ELMD has an Altman-Z score of 15.07. This indicates that ELMD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ELMD (15.07) is better than 93.62% of its industry peers.
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.07
ROIC/WACC1.69
WACC9.1%
ELMD Yearly LT Debt VS Equity VS FCFELMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ELMD has a Current Ratio of 5.19. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ELMD (5.19) is better than 76.06% of its industry peers.
A Quick Ratio of 4.84 indicates that ELMD has no problem at all paying its short term obligations.
ELMD has a better Quick ratio (4.84) than 78.19% of its industry peers.
Industry RankSector Rank
Current Ratio 5.19
Quick Ratio 4.84
ELMD Yearly Current Assets VS Current LiabilitesELMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

8

3. Growth

3.1 Past

ELMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.00%, which is quite impressive.
Measured over the past years, ELMD shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.42% on average per year.
ELMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.85%.
The Revenue has been growing by 11.82% on average over the past years. This is quite good.
EPS 1Y (TTM)58%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%23.53%
Revenue 1Y (TTM)14.85%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%13.07%

3.2 Future

Based on estimates for the next years, ELMD will show a very strong growth in Earnings Per Share. The EPS will grow by 26.83% on average per year.
Based on estimates for the next years, ELMD will show a quite strong growth in Revenue. The Revenue will grow by 12.42% on average per year.
EPS Next Y42.45%
EPS Next 2Y30.94%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year15.21%
Revenue Next 2Y13.44%
Revenue Next 3Y12.42%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ELMD Yearly Revenue VS EstimatesELMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ELMD Yearly EPS VS EstimatesELMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

ELMD is valuated quite expensively with a Price/Earnings ratio of 25.51.
Based on the Price/Earnings ratio, ELMD is valued a bit cheaper than the industry average as 78.19% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ELMD to the average of the S&P500 Index (26.43), we can say ELMD is valued inline with the index average.
The Price/Forward Earnings ratio is 20.26, which indicates a rather expensive current valuation of ELMD.
76.60% of the companies in the same industry are more expensive than ELMD, based on the Price/Forward Earnings ratio.
ELMD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.51
Fwd PE 20.26
ELMD Price Earnings VS Forward Price EarningsELMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ELMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ELMD is cheaper than 78.72% of the companies in the same industry.
92.55% of the companies in the same industry are more expensive than ELMD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.29
EV/EBITDA 15.48
ELMD Per share dataELMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

ELMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELMD has an outstanding profitability rating, which may justify a higher PE ratio.
ELMD's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)1.25
EPS Next 2Y30.94%
EPS Next 3Y26.83%

More info and screens

0

5. Dividend

5.1 Amount

ELMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTROMED INC

NYSEARCA:ELMD (6/4/2025, 8:21:54 PM)

20.15

-0.33 (-1.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-25 2025-08-25/amc
Inst Owners44.13%
Inst Owner Change15.62%
Ins Owners7.62%
Ins Owner Change2.54%
Market Cap169.06M
Analysts82.5
Price Target37.74 (87.3%)
Short Float %2.69%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)2.94%
Max EPS beat(2)19.83%
EPS beat(4)4
Avg EPS beat(4)121.43%
Min EPS beat(4)2.94%
Max EPS beat(4)422.88%
EPS beat(8)6
Avg EPS beat(8)63.79%
EPS beat(12)8
Avg EPS beat(12)51.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.89%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.31%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.61%
Revenue beat(12)6
Avg Revenue beat(12)0.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.78%
EPS NQ rev (1m)-4.44%
EPS NQ rev (3m)-6.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.22%
Revenue NQ rev (1m)0.3%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 25.51
Fwd PE 20.26
P/S 2.75
P/FCF 14.29
P/OCF 14.06
P/B 3.85
P/tB 3.9
EV/EBITDA 15.48
EPS(TTM)0.79
EY3.92%
EPS(NY)0.99
Fwd EY4.94%
FCF(TTM)1.41
FCFY7%
OCF(TTM)1.43
OCFY7.11%
SpS7.32
BVpS5.24
TBVpS5.17
PEG (NY)0.6
PEG (5Y)1.25
Profitability
Industry RankSector Rank
ROA 13.65%
ROE 16.3%
ROCE 20.38%
ROIC 15.35%
ROICexc 23.51%
ROICexgc 24%
OM 14.58%
PM (TTM) 11.66%
GM 77.55%
FCFM 19.25%
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ROICexc(3y)11.98%
ROICexc(5y)12.69%
ROICexgc(3y)12.25%
ROICexgc(5y)13.03%
ROCE(3y)11.36%
ROCE(5y)11.53%
ROICexcg growth 3Y14.49%
ROICexcg growth 5Y7.7%
ROICexc growth 3Y14.84%
ROICexc growth 5Y7.9%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
F-Score8
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 19.8%
Cap/Sales 0.32%
Interest Coverage 250
Cash Conversion 120.96%
Profit Quality 165.17%
Current Ratio 5.19
Quick Ratio 4.84
Altman-Z 15.07
F-Score8
WACC9.1%
ROIC/WACC1.69
Cap/Depr(3y)189.91%
Cap/Depr(5y)155.01%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58%
EPS 3Y30.66%
EPS 5Y20.42%
EPS Q2Q%23.53%
EPS Next Y42.45%
EPS Next 2Y30.94%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)14.85%
Revenue growth 3Y15.24%
Revenue growth 5Y11.82%
Sales Q2Q%13.07%
Revenue Next Year15.21%
Revenue Next 2Y13.44%
Revenue Next 3Y12.42%
Revenue Next 5YN/A
EBIT growth 1Y56.01%
EBIT growth 3Y27.97%
EBIT growth 5Y18.35%
EBIT Next Year137.93%
EBIT Next 3Y45.86%
EBIT Next 5YN/A
FCF growth 1Y648.35%
FCF growth 3Y48.86%
FCF growth 5Y48.48%
OCF growth 1Y2942.32%
OCF growth 3Y43.37%
OCF growth 5Y28.48%